OncoLensOncoLens
Menu
  • Solutions
  • Solutions
    • Solutions for Integrated Delivery Networks
    • Solutions for Community Cancer Centers
    • Solutions for Academic Institutions and NCI-Designated Cancer Centers
    • Solutions for Life Science
  • Resources
  • Resources
    • All Resources
    • Blog
    • Case Studies
    • Education
    • CME
    • News and Events
  • About
  • About
    • About Us
    • Meet Our Leadership Team
    • Meet Our Board of Directors
    • Awards
    • Contact Us
  • Careers
OncoLensOncoLens
  • Solutions
    Next Level Multidisciplinary Cancer Care Solutions for Cancer Centers, Oncology Practices and Life Science Organizations
    • Academic and NCI
      Cancer Center Solutions
      Leading institutions rely on OncoLens to drive clinical trial research, multidisciplinary care, and affiliate network engagement.
    • Community Cancer
      Center Solutions
      100+ community cancer centers and oncology practices use OncoLens to improve patient access to next level multidisciplinary care, accreditations, and quality improvement.
    • Integrated Delivery Network (IDN) Solutions
      The OncoLens platform drives standardization and provider engagement across the entire network.
    • Life Sciences Solutions
      Life Sciences Organizations work with OncoLens to collaborate with its oncology network, the largest in the United States.
    Next Level
    Multidisciplinary Cancer Care

    Explore the OncoLens Platform
  • Resources
    irAE webinar

    Project ECHO® Learning Series

    Expert-led telementoring sessions focused on irAE monitoring and management strategies for approved cancer immunotherapies.
    LEARN MORE and REGISTER
    Hosted by ACCC and Boston University. Sponsored by Bristol Myers Squibb.
    Powered by OncoLens.
    OncoLens Resources
    • All Resources
    • Blog
    • Case Studies
    • Education
    • CME
    • News and Events
  • About

    OncoLens provides a first of its kind
    multidisciplinary care platform.

    More than 10% of all cancer centers in the United States count on OncoLens to help improve outcomes through coordinated patient data, in-depth analysis, and actionable clinical decision support.

    2,000,000+

    Patients under Care in 200+ Cancer Centers

    143,000+

    Multidisciplinary Case Discussions

    24,000+

    Comprehensive Tumor Conferences
    About OncoLens

    • About Us
    • Meet Our Leadership Team
    • Awards
    • Meet Our Board of Directors
    Contact Us
    Careers
  • Careers
  • Solutions
    Next Level Multidisciplinary Cancer Care Solutions for Cancer Centers, Oncology Practices and Life Science Organizations
    • Academic and NCI
      Cancer Center Solutions
      Leading institutions rely on OncoLens to drive clinical trial research, multidisciplinary care, and affiliate network engagement.
    • Community Cancer
      Center Solutions
      100+ community cancer centers and oncology practices use OncoLens to improve patient access to next level multidisciplinary care, accreditations, and quality improvement.
    • Integrated Delivery Network (IDN) Solutions
      The OncoLens platform drives standardization and provider engagement across the entire network.
    • Life Sciences Solutions
      Life Sciences Organizations work with OncoLens to collaborate with its oncology network, the largest in the United States.
    Next Level
    Multidisciplinary Cancer Care

    Explore the OncoLens Platform
  • Resources
    irAE webinar

    Project ECHO® Learning Series

    Expert-led telementoring sessions focused on irAE monitoring and management strategies for approved cancer immunotherapies.
    LEARN MORE and REGISTER
    Hosted by ACCC and Boston University. Sponsored by Bristol Myers Squibb.
    Powered by OncoLens.
    OncoLens Resources
    • All Resources
    • Blog
    • Case Studies
    • Education
    • CME
    • News and Events
  • About

    OncoLens provides a first of its kind
    multidisciplinary care platform.

    More than 10% of all cancer centers in the United States count on OncoLens to help improve outcomes through coordinated patient data, in-depth analysis, and actionable clinical decision support.

    2,000,000+

    Patients under Care in 200+ Cancer Centers

    118,000+

    Multidisciplinary Case Discussions

    19,000+

    Comprehensive Tumor Conferences
    About OncoLens

    • About Us
    • Meet Our Leadership Team
    • Awards
    • Meet Our Board of Directors
    Contact Us
    Careers
SCHEDULE A DEMO

OncoLens Resources

  • ALL
  • Blog
  • Case Studies
  • CME
  • Education
  • News and Events

OncoLens QI Project Helps Improve Biomarker Testing Rates for Eligible Patients at Cancer Programs

The cancer programs included an NCI center, a regional IDN and a community cancer center. The life science industry sponsored program facilitated the assessment of current practices and the derivation of insights into local barriers to testing. The program subsequently addressed these barriers resulting in the overall improvement of NGS testing and targeted therapies in solid tumors possessing a rare gene fusion.
DOWNLOAD CASE STUDY
  • 1
  • 2
  • 3
May 30, 2023 | Education

Using Live Patient-specific Tumor Tissue to Predict Therapeutic Response(s) in HGG Patients Before Treatment Initiation

Read More
Apr 30, 2023 | CME

Project ECHO®: Dermatologic Toxicities with Immune Checkpoint Inhibitors

Read More
Apr 25, 2023 | Education

Functional Precision Oncology: Revolutionizing the Future of Cancer Care by Predicting Individual Patient Response(s) to Oncology Drugs

Read More
Apr 16, 2023 | CME

Aplastic Anemia Educational Series

Read More
Mar 27, 2023 | CME

Project ECHO®: Hepatobiliary Toxicities with Immune Checkpoint Inhibitors

Read More
Mar 22, 2023 | Education

Building and Engaging Affiliate Cancer Care Networks Webinar

Read More
Mar 20, 2023 | CME

Project ECHO®: Neurological Toxicities with Immune Checkpoint Inhibitors

Read More
Mar 03, 2023 | Blog

OncoLens and Cancer Centers Overcome Clinical Trial Patient Recruitment Challenges

Read More
Jan 26, 2023 | CME

Project ECHO®: Rheumatologic Toxicities with Immune Checkpoint Inhibitors

Read More
Jan 19, 2023 | Blog

OncoLens Empowers Molecular Tumor Boards

Read More
Jan 18, 2023 | News and Events

Breaking Down Silos in Cancer Care: “Who The Health Started That?” Podcast Episode With Anju Mathew

Read More
Dec 13, 2022 | Blog

OncoLens Streamlines NAPRC Accreditation through Advanced Patient Tracking and Analytics Reporting

Read More
Project ECHO
Dec 06, 2022 | News and Events

ACCC and Boston University Present the Project ECHO® Eight-Part Webinar Series, Powered by OncoLens

Read More
Nov 28, 2022 | CME

Project ECHO®: Endocrine Toxicities with Immune Checkpoint Inhibitors

Read More
Oct 25, 2022 | CME

Project ECHO®: Gastroenterology Toxicities with Immune Checkpoint Inhibitors

Read More
women-led digital health
Sep 22, 2022 | News and Events

Women-Led Digital Health: The Women Behind Digital Health Innovations and the Journey to Success

Read More
Sep 20, 2022 | CME

Project ECHO®: Cardiovascular Toxicities with Immune Checkpoint Inhibitors

Read More
Aug 26, 2022 | CME

Project ECHO® Learning Series: Telementoring to Manage Immune-Related Adverse Events in Patients Receiving Cancer Immunotherapies

Read More
MIB Agents logo
Jul 19, 2022 | News and Events

MIB Agents Selects OncoLens to Support and Expand its TURBO Program Globally

Read More
Optimizing Frontline Immunotherapy in Advanced Non-Small Cell Lung Cancer: Program Highlights
May 12, 2022 | CME

Optimizing Frontline Immunotherapy in Advanced Non-Small Cell Lung Cancer

Read More
oncolens video
Mar 15, 2022 | Education

Quality Improvement Program Webinar—Breast and Ovarian Cancer Biomarker Testing

Read More
  • 1
  • 2
  • 3
OncoLens logo
SOC2 Certified
© 2017- OncoLens | All Rights Reserved